» Articles » PMID: 36013951

New Variants of Pseudomonas High-Risk Clone ST233 Associated with an Outbreak in a Mexican Paediatric Hospital

Abstract

Recent multidrug resistance in has favoured the adaptation and dissemination of worldwide high-risk strains. In June 2018, 15 strains isolated from patients and a contaminated multi-dose meropenem vial were characterized to assess their association to an outbreak in a Mexican paediatric hospital. The strains were characterized by antibiotic susceptibility profiling, virulence factors' production, and biofilm formation. The clonal relationship among isolates was determined with pulse-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST) sequencing. Repressor genes for the MexAB-OprM efflux pump were sequenced for haplotype identification. Of the strains, 60% were profiled as extensively drug-resistant (XDR), 33% as multidrug-resistant (MDR), and 6.6% were classified as sensitive (S). All strains presented intermediate resistance to colistin, and 80% were sensitive to aztreonam. Pyoverdine was the most produced virulence factor. The PFGE technique was performed for the identification of the outbreak, revealing eight strains with the same electrophoretic pattern. ST235 and ten new sequence types (STs) were identified, all closely related to ST233. ST3241 predominated in 26.66% of the strains. Twenty-five synonymous and seventeen nonsynonymous substitutions were identified in the regulatory genes of the MexAB-OprM efflux pump, and was the most variable gene. Six different haplotypes were identified. Strains from the outbreak were metallo-β-lactamases and phylogenetically related to the high-risk clone ST233.

Citing Articles

High-risk clones harboring β-lactamases: 2024 update.

Flores-Vega V, Partida-Sanchez S, Ares M, Ortiz-Navarrete V, Rosales-Reyes R Heliyon. 2025; 11(1):e41540.

PMID: 39850428 PMC: 11754179. DOI: 10.1016/j.heliyon.2024.e41540.


Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant Clinical Strains: A Challenge for Tertiary Care Hospitals.

Gondal A, Choudhry N, Niaz A, Yasmin N Antibiotics (Basel). 2024; 13(2).

PMID: 38391577 PMC: 10886086. DOI: 10.3390/antibiotics13020191.


International Clones of High Risk of Acinetobacter Baumannii-Definitions, History, Properties and Perspectives.

Shelenkov A, Akimkin V, Mikhaylova Y Microorganisms. 2023; 11(8).

PMID: 37630675 PMC: 10459012. DOI: 10.3390/microorganisms11082115.


Nosocomial Pathogens and Antimicrobial Resistance: Modern Challenges and Future Opportunities.

Freitas A, Werner G Microorganisms. 2023; 11(7).

PMID: 37512858 PMC: 10386484. DOI: 10.3390/microorganisms11071685.


Whole-genome sequencing reveals high-risk clones of in Guangdong, China.

Zhao Y, Chen D, Ji B, Zhang X, Anbo M, Jelsbak L Front Microbiol. 2023; 14:1117017.

PMID: 37125174 PMC: 10140354. DOI: 10.3389/fmicb.2023.1117017.

References
1.
Ahmed S, Rudden M, Smyth T, Dooley J, Marchant R, Banat I . Natural quorum sensing inhibitors effectively downregulate gene expression of Pseudomonas aeruginosa virulence factors. Appl Microbiol Biotechnol. 2019; 103(8):3521-3535. PMC: 6449319. DOI: 10.1007/s00253-019-09618-0. View

2.
Garcia-Castillo M, Del Campo R, Morosini M, Riera E, Cabot G, Willems R . Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals. J Clin Microbiol. 2011; 49(8):2905-10. PMC: 3147750. DOI: 10.1128/JCM.00753-11. View

3.
Seyman D, Inan D, Sepin Ozen N, Ogunc D . An outbreak of Pseudomonas aeruginosa infective endocarditis subsequent to coronary angiography. Rev Chilena Infectol. 2014; 31(3):268-73, 261-7. DOI: 10.4067/S0716-10182014000300003. View

4.
Micek S, Wunderink R, Kollef M, Chen C, Rello J, Chastre J . An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance. Crit Care. 2015; 19:219. PMC: 4446947. DOI: 10.1186/s13054-015-0926-5. View

5.
Pesingi P, Singh B, Pesingi P, Bhardwaj M, Singh S, Kumawat M . MexAB-OprM Efflux Pump of Offers Resistance to Carvacrol: A Herbal Antimicrobial Agent. Front Microbiol. 2019; 10:2664. PMC: 6877666. DOI: 10.3389/fmicb.2019.02664. View